Public vaccines not expected in county until February or April

Public vaccines not expected in county until February or April

Public COVID-19 vaccines are not expected to arrive in Matagorda County until February at the earliest and may not arrive until April.

In cooperation with the EOC, MRMC will engage its local press partners and launch a multi-channel outreach campaign when COVID-19 vaccines are made available to the general public.

Due to an overwhelming response for the COVID-19 vaccine, leaving MRMC with far more requests than they have additional vaccine doses at this time, the request form has been closed.

MRMC will re-open the form if we expect additional doses for Phase 1B patients to become available through MRMC in the future.

If you have already filled out the request form, your information is being held on file and will be loaded into a contact database if needed.

If you qualify as a Phase 1B patient, please do not pass up an opportunity to receive the vaccine from any qualified healthcare provider. Please do NOT wait for MRMC to receive additional vaccine doses.

Mortality and morbidity data collected over the course of the COVID-19 pandemic clearly demonstrates that COVID-19 has the most severe effects on people who are 65 years and older and individuals with comorbidities.

Protecting these higher-risk individuals is of the utmost concern in addressing the COVID-19 pandemic. According to Texas death certificate data, more than 70 percent of the deaths directly caused by COVID-19 are among people 65 years and older.

Additionally, a growing body of scientific evidence shows that adults of any age with certain underlying medical conditions have an increased risk of severe disease, defined as hospitalization, admission to the intensive care unit, mechanical ventilation or death. In Texas, Phase 1B of vaccination will focus on people for whom there is strong and consistent evidence that COVID-19 makes them more likely to become very sick or die.

Preventing the disease among people who have these risk factors will dramatically reduce the number of Texans who die from the disease and relieve pressure on the healthcare system by reducing hospital and ICU admissions. Vaccination will also reduce absenteeism among the front-line workers at the greatest risk of severe disease and protect individuals at risk for health inequities.

Because Phase 1B provides vaccine to higher-risk people regardless of their work sector or status, it will provide protection for a number of critical populations at an increased risk of getting COVID-19: communities that are disproportionately affected by COVID-19 and other chronic diseases; teachers and school staff who ensure that Texas children can learn in a safe environment; social services workers who ensure that those in need receive care and support; workers who maintain critical infrastructure to support the Texas economy; and other front-line workers who are unable to work remotely and so are more likely to be exposed.

As Texas progresses into Phase 1B in the coming weeks, the state will work with vaccine providers and local partners to ensure that people who are 65 and older or have the medical conditions listed below and who also work in front-line and critical industries have access to the vaccine so they will be protected from COVID-19 while on the job. Texas equally will strive to ensure vaccine reaches communities with health disparities in accordance with Texas Vaccine Allocation Guiding Principles. Communication and outreach will encourage vaccine uptake among these populations during Phase 1B.

Texas Phase 1B Vaccine Priorities

• People 65 years of age and older

• People 16 years of age and older with at least one chronic medical condition that puts them at increased risk for severe illness from the virus that causes COVID-19, such as but not limited to:

• Cancer

• Chronic kidney disease

• COPD (chronic obstructive pulmonary disease)

• Heart conditions, such as heart failure, coronary artery disease or cardiomyopathies

• Solid organ transplantation

• Obesity and severe obesity (body mass index of 30 kg/m2 or higher)

• Pregnancy

• Sickle cell disease

• Type 2 diabetes mellitus

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.